Lorazepam: Effects on Sleep and Withdrawal Phenomena
The DOI matches its Crossref record.
Abstract
Lorazepam, an anxiolytic drug, was evaluated in a 2-mg dose using a 16-night protocol including 7 nights of drug trial. Initially and with continued use the drug was moderately effective in inducing and maintaining sleep. Side effects included episodes of memory impairment and confusion in 2 subjects and group mean increases in daytime anxiety and tension with continued drug use. Following drug withdrawal, there was a marked and significant worsening of sleep above baseline levels (rebound insomnia) on the third night as well as significant increases in tension and anxiety the next day. The peak degree of withdrawal sleep disturbance was several times the peak degree of sleep improvement with drug administration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This was confirmed by other studies [53-59].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [54]
Citations
Cites
Still being checked.
Cited by
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Maurice-Szamburski, A., Auquier, P., Viarre-Oreal, V., Cuvillon, P., Carles, M., Ripart, J., Honore, S., Triglia, T., Loundou, A., Leone, M., et al. (2015) · JAMA · doi:10.1001/jama.2015.1108 · Cited by 212
Drug effects on REM sleep and on endogenous depression
Vogel, G. W., Buffenstein, A., Minter, K., & Hennessey, A. (1990) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80159-9 · Cited by 198
Quazepam: Hypnotic Efficacy and Side Effects
Kales, A. (1990) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02545.x · Cited by 188
Self-citationThe use of lorazepam TID for chronic insomnia
Bonnet, M. H., & Arand, D. L. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199903000-00004 · Cited by 179
Benzodiazepines and sleep architecture: a systematic review
Sousa Martins Silva, A., de Mendonça, F. M. R., de Mendonça, G. P. R. R., Souza, L. C., Galvão, L. P., Paiva, H. S., de Azevedo Marques Périco, C., Torales, J., Ventriglio, A., & Maurício Castaldelli-Maia, J. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210618103344 · Cited by 149
Obermeyer, W. H., & Benca, R. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70287-5 · Cited by 118
Rebound insomnia and newer hypnotics
LADER, M. H. (1992) · Psychopharmacology · doi:10.1007/bf02245108 · Cited by 76
Alprazolam: Effects on Sleep and Withdrawal Phenomena
Kales, A., Bixler, E. O., Vela‐Bueno, A., Soldatos, C. R., & Manfredi, R. L. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb03058.x · Cited by 46
Self-citationBatty, G. M., Oborne, C. A., Swift, C. G., & Jackson, S. H. D. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200010)15:10<892::aid-gps213>3.0.co;2-x · Cited by 35
Withdrawal Reactions after Stopping Hypnotics in Patients with Insomnia
LADER, M. H. (1998) · CNS Drugs · doi:10.2165/00023210-199810060-00004 · Cited by 35
Clinical Pharmacology of Sleep
Pandi-Perumal, S. R., & Monti, J. M. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7440-3 · Cited by 31
Hoey, L. L., Nahum, A., & Vance‐Bryan, K. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02854.x · Cited by 29
Characterization of benzodiazepine withdrawal in high- and low-dose dependent psychiatric inpatients
Schmauss, C., Apelt, S., & Emrich, H. M. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90109-2 · Cited by 29
Obermeyer, W. H., & Benca, R. M. (1999) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(05)70131-6 · Cited by 20
Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men
Guldner, J., Trachsel, L., Kratschmayr, C., Rothe, B., Holsboer, F., & Steiger, A. (1995) · Psychopharmacology · doi:10.1007/bf02246085 · Cited by 12
Comparison of Lorazepam and Flurazepam as Hypnotic Agents in Chronic Insomniacs
McClure, D. J., Walsh, J., Chang, H., Olah, A., Wilson, R., & Pecknold, J. C. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03101.x · Cited by 13
Rebound and withdrawal with benzodiazepine and non-benzodiazepine hypnotic medication
LADER, M. H. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7440-3_15 · Cited by 10
The influence of lorazepam medication upon the transfer properties of the brain during sleep in man
Roschke, J., Wagner, P., & Aldenhoff, J. B. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90294-v · Cited by 7
Sleep Disorder and its Treatment: From Nature to Laboratory
Varshney, M., Saha, S., Prinsa, P., & Jakhmola, V. (2024) · Majalah Obat Tradisional · doi:10.22146/mot.86645 · Cited by 7
McCall, V. W. (2010) · Medical psychiatry · doi:10.3109/9781420080803.034 · Cited by 5
Mechanisms of Benzodiazepine Drug Dependence
Vgontzas, A. N., & Kales, A. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_19 · Cited by 1
Self-citationThe Future of Anxiolytic Drug Therapy
Ayd, F. J. (1990) · International Review of Psychiatry · doi:10.3109/09540269009026608
Introduction: The Origins and Rise of Benzodiazepines
Miller, M. M., & Peppin, J. F. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780197517277.003.0001
Vela‐Bueno, A. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_14
The family business: turning sleep into dreams
Kales, A., Kales, J. D., & Kales, H. C. (2023) · SLEEP Advances · doi:10.1093/sleepadvances/zpad036
Self-citationSheehan, D. V. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as22
Metadata
- Authors
- Kales, A., Bixler, E. O., Soldatos, C. R., Jacoby, J. A., & Kales, J. D.
- Affiliations
- Pennsylvania State University (US)
- Venue
- Pharmacology
- Publisher
- S. Karger AG
- Published
- 2008-06-04
- Volume
- 32
- Issue
- 3
- Pages
- 121-130
- ISSN
- 0031-7012 (ISSN-L)
- 1423-0313
- OpenAlex
- W2043268064
- Semantic Scholar
- 2ce9354d95f7959932dcc616dded007a0ef5289a
- Cited by
- 29
- References
- 0
- Citations by year
- 2024: 2 · 2023: 1 · 2021: 1 · 2020: 2 · 2016: 1 · 2015: 1
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- lorazepam, anxiolytics, sleep induction, sleep maintenance, rebound insomnia, drug withdrawal, tension, memory impairment, confusion, adverse effects
- MeSH terms
- Adult, Humans, Sleep Initiation and Maintenance Disorders, Lorazepam, Memory Disorders, Middle Aged, Sleep, Sleep Stages, Substance Withdrawal Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.